Try our Advanced Search for more refined results
County of Lake v. Purdue Pharma L.P. et al
Case Number:
1:18-op-45032
Court:
Nature of Suit:
Judge:
Firms
- Baker & Hostetler
- Bartlit Beck
- Covington & Burling
- Dickinson Wright
- Jones Day
- Marcus & Shapira
- Morgan Lewis
- Murray Murphy
- Napoli Shkolnik
- Nixon Peabody
- Plevin & Gallucci
- Taft Stettinius
- Thompson Hine
- Thrasher Dinsmore
- Vorys
- Weil Gotshal
- Zuckerman Spaeder
Companies
- Allergan PLC
- Cardinal Health Inc.
- Cencora Inc.
- Cephalon Inc.
- CVS Health Corp.
- Endo International PLC
- Giant Eagle Inc.
- Hikma Pharmaceuticals PLC
- Johnson & Johnson
- McKesson Corp.
- Omnicare Inc.
- Par Pharmaceutical Cos. Inc.
- Purdue Pharma LP
- Rite Aid Corp.
- Teva Pharmaceutical Industries Ltd.
- Walgreens Boots Alliance Inc.
- Walmart Inc.
- West-Ward Pharmaceutical Corp.
Sectors & Industries:
-
October 01, 2021
Counties Say Opioid Trial Can Redress 'Great Stress' Of Crisis
The two Ohio counties set to battle national pharmacies starting Monday in a key opioid bellwether have strong steel and manufacturing roots and see the trial as their chance to hold companies accountable for the extreme financial stress the crisis has brought to their already struggling communities.
-
September 29, 2021
7 Key Details As Pharmacy Giants Head To 1st Opioid Trial
After years of bobbing and weaving, pharmacy titans CVS, Walgreens and Walmart are poised to go toe-to-toe with heavyweight plaintiffs lawyers in the first opioid trial targeting the pharmacy sector. Here, Law360 looks at the showdown's lead lawyers, biggest uncertainties and intensely acrimonious atmosphere.
-
August 26, 2021
Rite Aid Strikes Deal To Avert Opioid MDL's 1st Pharmacy Trial
A years-in-the-making opioid trial against major pharmacy chains won't include Rite Aid Corp., which revealed a deal Thursday to avoid going before an Ohio federal jury on allegations it unlawfully dispensed and distributed massive amounts of prescription narcotics.
-
August 13, 2021
Ohio Counties Don't Want 'Legal Opioid' Talk In Bellwether
Two Ohio counties set for an October bellwether trial over the opioid crisis want their pharmacy-chain adversaries blocked from calling prescription opioids "legal opioids," saying it will only confuse matters since legality is dependent on context.
-
June 23, 2021
Judge Backtracks On Juror Vaccine Mandate In Opioid MDL
An Ohio federal judge said on Wednesday he wouldn't automatically throw out potential jurors in the national multidistrict opioid litigation because they are unvaccinated against COVID-19, undoing an earlier order requiring juror vaccinations.
-
June 22, 2021
Vaccine Mandate May Skew Opioid MDL Jury, Pharmacies Say
Limiting the pool of potential jurors to only those who have been fully vaccinated against COVID-19 could unfairly skew the jury in national multidistrict opioid litigation, pharmacies are telling an Ohio federal judge.
-
May 28, 2021
Key Opioid Trials To Watch As Cases Heat Up Nationwide
With the coronavirus crisis cooling down, a pressure cooker of opioid litigation is heating up with long-awaited trials across the country. Here, Law360 maps out the hottest cases and spotlights must-know details in trials that are underway or imminent.
-
January 03, 2021
2021 Trials To Watch As Litigants Return To Court — Hopefully
After a year in which the coronavirus pandemic swiped numerous important trials off the table, 2021 is widely hoped to bring broad vaccine availability and a return to the courtroom for many who have been awaiting their days in court.
-
November 10, 2020
CVS, Rite Aid Say Doctors Also Liable For Prescribing Opioids
Pharmacy chains including CVS and Rite Aid on Monday swung back at a bid by two Ohio counties to strike the chains' claims against health care workers who wrote opioid prescriptions, saying their arguments rest on "fiction."
-
September 22, 2020
Pharmacies Lose Bid To Revisit Ruling On Their Opioid Duties
The Ohio federal judge overseeing opioid litigation on Tuesday refused to reconsider an earlier decision allowing two Ohio counties' opioid claims to go forward, reaffirming his conclusion that pharmacies should protect against types of diversion beyond theft.